Skip to content
Lower risk Drug recall · FDA · Published April 1, 2022

Ritedose 23.4% Sodium Chloride Injection Recall: Incorrect Barcode Labeling

Ritedose recalls 23.4% Sodium Chloride Injection with incorrect barcode labeling that may cause confusion with rocuronium bromide. Affected products have specific NDC and batch numbers.

🇺🇸 FDA recall #D-0745-2022DrugRitedose ›
Take action

Contact the company

Recalling firmThe Ritedose Corporation1 Technology Cir · Columbia, SC 29203-9591
✎ GovInfoNow plain-language explainer

Ritedose is recalling a specific type of saline injection due to a barcode error that could lead to confusion with a different medication. This mistake might cause incorrect use if the product is mistaken for rocuronium bromide injection. Read more at govinfonow.com/recall/35024-ritedose-23-4-sodium-chloride-injection-recall-incorrect-barcode-labeling.

Source Summary by GovInfoNow · govinfonow.com/recall/35024-ritedose-23-4-sodium-chloride-injection-recall-incorrect-barcode-labeling · Updated August 18, 2026 · FDA enforcement record: FDA #D-0745-2022

Cite this page

“Ritedose 23.4% Sodium Chloride Injection Recall: Incorrect Barcode Labeling.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35024-ritedose-23-4-sodium-chloride-injection-recall-incorrect-barcode-labeling. Based on FDA recall #D-0745-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0745-2022%22&limit=1).

The Food and Drug Administration announced on April 1, 2022, that The Ritedose Corporation voluntarily recalled 3,795 prefilled syringes of 23.4% Sodium Chloride Injection due to an incorrect barcode. The agency said the error misidentifies the product as rocuronium bromide injection.

How to tell if you have it

  • Brand: Ritedose
  • Product: 23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring
  • NDC: 65302-509-30
  • Lots: 210137-01, 220026-01, 220050-01
  • Distribution: Nationwide in the USA

The hazard

The product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL, according to the FDA.

Context

GovInfoNow's records show The Ritedose Corporation has one other recall on record since July 21, 2023, involving Cromolyn Sodium Oral Solution due to a CGMP deviation risk. Other recent recalls of similar products include Fresenius Kabi 0.9% Sodium Chloride Injection Recall (March 11, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and ICU Medical Recalls Potassium Chloride Injection Due to Label Error (Oct. 29, 2025).

How to tell if you have this one

Check for the product name '23.4% Sodium Chloride Injection, 120 mEq per 30 mL' on the label. Look for NDC number 65302-509-30 and batch numbers 210137-01, 220026-01, or 220050-01.

  • Brand
    Ritedose
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Verify the product name and NDC number to ensure it matches the correct saline injection.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: Apr 1, 202212. FDA classified it Class III: Apr 5, 202223. Published in FDA’s Enforcement Report: Apr 13, 202234. FDA terminated the recall: Dec 2, 202242022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0745-2022 (April 1, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0745-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA